NCT07702916

Brief Summary

A previous study in schools in rural Madagascar found that a bundle of hygiene-focused interventions substantially improved girls' learning outcomes. This study disentangles the effects of physical infrastructure (latrines, handwashing basins) from other intervention components (peer sensitization and free sanitary pad distribution) in a cluster-randomized trial across 140 secondary schools in the Amoron'i Mania region. The trial originally measured learning and psychosocial wellbeing outcomes and was prospectively registered with the AEA RCT Registry (AEARCTR-0014423). The study team is now also collecting secondary health biomarker outcomes (e.g., salivary cortisol and blood-based C-reactive protein) and is registering those health biomarker endpoints with ClinicalTrials.gov.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,080

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Oct 2024Dec 2026

Study Start

First participant enrolled

October 1, 2024

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

July 1, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

July 14, 2026

Status Verified

June 1, 2026

Enrollment Period

1.8 years

First QC Date

July 1, 2026

Last Update Submit

July 8, 2026

Conditions

Keywords

menstrual hygiene managementmenstrual hygiene interventionmenstrual stigma reduction interventionadolescentsschool-based interventionWASH (water, sanitation, and hygiene)Madagascarcluster-randomized trialbiomarkerspsychosocial stresscortisolinflammationanemiaurinary tract infectionenvironmental enteric dysfunctiongut microbiomemenstrual stigma

Outcome Measures

Primary Outcomes (6)

  • Learning - Academic Test Scores

    Standardized math/literacy test scores and official school grades (140-school full evaluation sample and 80-school biomarker subsample)

    Up to 19 months

  • Learning - School Grades

    Official school grades (140-school full evaluation sample and and 80-school biomarker subsample)

    Up to 19 months

  • Psychosocial Wellbeing - Heart Rate

    Objective stress measure: heart rate, beats per minute (140-school full evaluation sample and 80-school biomarker subsample)

    Up to 19 months

  • Psychosocial Wellbeing - Blood Pressure

    Objective stress measure: systolic/diastolic blood pressure, mmHg (140-school full evaluation sample and 80-school biomarker subsample)

    Up to 19 months

  • Psychosocial Wellbeing - Salivary Cortisol Reactivity

    Salivary cortisol reactivity (80-school biomarker subsample). Cortisol reactivity, calculated as the area under the curve with respect to increase (AUCi), based on samples collected at clinic arrival (baseline), 5-8 minutes pre-venipuncture, and 20 minutes post-venipuncture. AUCi is calculated using the trapezoidal method: the area under the curve with respect to ground (AUCg) is first calculated by summing the areas of the trapezoids formed between each pair of consecutive cortisol values and their corresponding time interval, then subtracting the area under the baseline value across the total sampling duration. This is expressed as AUCg = Σ\[(Ci + Ci+1)/2 × Ti\], where Ci is the cortisol concentration at a given timepoint, Ci+1 is the concentration at the subsequent timepoint, and Ti is the time interval between them. AUCi = AUCg - (baseline cortisol × total sampling duration). Reported in µg/dL×min.

    Up to 19 months

  • Menstrual stigma

    Self-reported menstrual stigma (140-school full evaluation sample)

    Up to 17 months

Secondary Outcomes (17)

  • Hygiene Knowledge

    Up to 17 months

  • Hygiene Behavior

    Up to 17 months

  • Menstrual Knowledge

    Up to 17 months

  • Menstrual Behavior

    Up to 17 months

  • Student/Teacher Motivation

    Up to 17 months

  • +12 more secondary outcomes

Study Arms (4)

Control

NO INTERVENTION

No intervention

School infrastructure only

EXPERIMENTAL

Construction of latrines and handwashing basins

Other: School infrastructure

Peer leadership/sensitization + sanitary pads

EXPERIMENTAL

Young Girl Leaders program, teacher sensitization, WASH competition, free sanitary pad vouchers

Behavioral: Peer leadership/sensitization + sanitary pads

Full package

EXPERIMENTAL

Combination of all interventions: Construction of latrines and handwashing basins and Peer leadership/sensitization + sanitary pads

Behavioral: Peer leadership/sensitization + sanitary padsOther: School infrastructure

Interventions

Young Girl Leaders program, teacher sensitization, WASH competition, free sanitary pad vouchers

Full packagePeer leadership/sensitization + sanitary pads

Construction of latrines and handwashing basins

Full packageSchool infrastructure only

Eligibility Criteria

Age11 Years - 21 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Girl identified in the Kilonga 2 evaluation sample (randomly selected during the December 2024-January 2025 baseline from class registers across the 140 participating schools); participants were 11-20 years old at baseline enrollment and are approximately 12-21 years old at the time of endline/health-outcomes data collection (May-August 2026)
  • Full evaluation sample (n\~3,080; \~22 girls/school): all girls in the Kilonga 2 sample across the 140 schools are eligible for the cognitive, self-reported psychosocial, and non-biospecimen health outcomes, collected at the social-science endline.
  • Biomarker subsample (n\~1,360; \~17 girls/school): girls attending one of the 80 schools selected for the health biomarker subsample (logistically accessible for biospecimen collection and cold-chain maintenance) are additionally eligible for salivary cortisol and blood-based C-reactive protein outcomes.
  • Informed consent obtained from parent/legal guardian, and assent obtained from the participant herself

You may not qualify if:

  • Adolescents (or their parent/legal guardian) who refuse to participate or who withdraw consent/assent at any time
  • Adolescents for whom sample collection is judged impossible or contraindicated at the time of collection (e.g., health status precluding collection)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laboratoire d'Analyses Médicales Malagasy

Antananarivo, Madagascar

Location

MeSH Terms

Conditions

Urinary Tract InfectionsMalnutritionInflammationAnemia

Interventions

Menstrual Hygiene Products

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesNutrition DisordersNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Feminine Hygiene ProductsEquipment and Supplies

Study Officials

  • Audrie Lin, PhD, MPH

    University of California Santa Cruz

    PRINCIPAL INVESTIGATOR
  • Karen Macours, PhD

    Paris School of Economics

    PRINCIPAL INVESTIGATOR
  • Duncan Webb, PhD

    Nova School of Business and Economics

    PRINCIPAL INVESTIGATOR
  • Mariachiara Iannuzzi, MS

    Paris School of Economics

    PRINCIPAL INVESTIGATOR
  • Oscar M Díaz, MS

    Paris School of Economics

    PRINCIPAL INVESTIGATOR
  • William Amedanou, MS

    Paris School of Economics

    PRINCIPAL INVESTIGATOR
  • Juliet Ellenbach, BS

    University of California Santa Cruz

    PRINCIPAL INVESTIGATOR
  • Eliane Z Ralison

    Consultant Associates

    PRINCIPAL INVESTIGATOR
  • Andry M Andrianarivelo, MD

    Laboratoire d'Analyses Médicales Malagasy

    PRINCIPAL INVESTIGATOR
  • Ianja I Razanadrakoto, MD

    Laboratoire d'Analyses Médicales Malagasy

    PRINCIPAL INVESTIGATOR
  • Tantely J Ramontalambo, MD

    Laboratoire d'Analyses Médicales Malagasy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The outcome assessment team is separate from the implementation team, however due to the nature of the interventions there may be intervention contents visible during the assessment. Data analysis will be masked to randomization status of clusters.
Purpose
PREVENTION
Intervention Model
FACTORIAL
Model Details: This is a 2×2 factorial design crossing two intervention components, each present or absent: (1) physical infrastructure (construction of latrines and handwashing basins) and (2) a sensitization and sanitary pad distribution bundle (Young Girl Leaders peer program, teacher sensitization, WASH committee/competition, and free sanitary pad vouchers). The four resulting arms are: Control (neither component), Infrastructure only, Sensitization+pads only, and the Full package (both components combined). The factorial structure allows estimation of each component's independent effect as well as any complementarity (interaction) between the two - for example, whether girls can only act on improved hygiene knowledge if handwashing infrastructure is also available at school.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2026

First Posted

July 14, 2026

Study Start

October 1, 2024

Primary Completion

August 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 14, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be made publicly available. Per the approved protocol (UCSC IRB: HS-FY2025-210), all survey and biospecimen data are de-identified at the point of collection; identifiers are stored separately from research data and accessible only to authorized project personnel.

Locations